Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02174562 · ClinicalTrials.gov registry record · NA

Improving Medication Adherence in Older African Americans With Diabetes

A NA study, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT02174562: Completed NA study, sponsored by Thomas Jefferson University.

NCT02174562 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02174562, a NA study, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

This research aims to help older African Americans with diabetes and mild memory problems improve how they take their medications and control their diabetes. This may preserve their independence and health, prevent cognitive and functional decline, and reduce health care costs. As the population ages and becomes more racially diverse, finding ways to achieve these outcomes has great public health importance.

Primary Outcome

Percent of participants who had a reduction (improvement) of at least .5% in hemoglobin A1c from baseline to 6 months

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Primary Care-Occupational Therapy

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2014-07
Est. Completion 2019-12
Phase NA
Thomas Jefferson University

292 total trials

What the finished NCT02174562 record still lists

NCT02174562 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT02174562 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02174562 about?

NCT02174562 is a clinical study titled "Improving Medication Adherence in Older African Americans With Diabetes". This research aims to help older African Americans with diabetes and mild memory problems improve how they take their medications and control their diabetes. This may preserve their independence and health, prevent cognitive and functional decline, and reduce health care costs. As the population age...

What is the current status of trial NCT02174562?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2014-07. Estimated completion is 2019-12.

What interventions are being tested in trial NCT02174562?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Primary Care-Occupational Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02174562?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02174562's enrollment target sits among peer trials

101 840th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02174562, the US trial registry maintained by the National Library of Medicine. NCT02174562 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.